Corrigendum: High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine.  Galvez SJ, Altice FL, Meteliuk A, Ivasiy R, Machavariani E, Farnum SO, Fomenko T, Islam Z, Ma...

Integrated biobehavioral surveillance among people who inject drugs in Ukraine, 2007-2020.  Dumchev K, Kovtun O, Salnikov S, Titar I, Saliuk T.  Int J Drug Policy. 2024 Jan 11:104319. doi: 10.1016/j.drugpo.2024.104319. Epub ahead of pr...

Measuring sustainability of opioid agonist therapy programs in the context of transition from global fund support.  Stuikyte R, Varentsov I, Cook C, Dvoriak S.  Harm Reduct J. 2024 Jan 12;21(1):7. doi: 10.1186/s12954-024-00931-0. Errat...

Community-led monitoring of opioid agonist treatment including WHO quality of life indicators. The CLM initiative led to policy changes in Ukraine, Georgia, Montenegro, and Moldova. For instance, in Ukraine, the research revealed gaps in psycholo...

Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?  Dellamura P, Meteliuk A, Fomenko T, Rozanova J.  Front Public Health. 2024...

Qualitative exploration of the early experiences of opioid use disorder patients from private clinics after Russia's invasion of Ukraine in five major cities in Ukraine.  Mazhnaya A, Meteliuk A, Pykalo I, Altice FL.  Front Public Healt...